Allergy Testing of Soldiers Prepared for International Mission
NCT05807958 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2025-02-28
Summary
The goal of this prospective mono centric study is to identify relevant commercially available allergen extracts for allergy testing in soldiers prepared for international mission.
Participants will receive a skin prick test with the skin prick automated test device including 22 allergens and 2 controls on both forearms.
Conditions
- Adult Military Personnel
Interventions
- DEVICE
-
Skin Prick Automated Test
A skin prick automated test will be performed in each participant.
Sponsors & Collaborators
-
Queen Astrid Military Hospital
lead OTHER
Principal Investigators
-
Ilan Baron, MD · Military Hospital Queen Astrid
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-03-14
- Primary Completion
- 2024-03-08
- Completion
- 2025-02-07
Countries
- Belgium
Study Locations
More Related Trials
-
Impact of Microbial Exposure of the Habitat at the Time of Birth on the Development of Allergic Diseases.
NCT04189978 ·Status: UNKNOWN
-
Randomized Evaluation of Ten Allergy Skin Prick Test Devices
NCT03509766 ·Status: COMPLETED ·Phase: NA
-
Effect of Intranasal Anti-IgE Antibodies on IgE Production
NCT03019237 ·Status: COMPLETED ·Phase: NA
-
Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration
NCT00719511 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
NCT00461721 ·Status: COMPLETED
-
Monitoring Allergen Immunotherapy in Allergic Rhinitis
NCT05621356 ·Status: UNKNOWN
-
Nut Allergy Study: Double-blind Challenge and Oral Desensitization
NCT01502878 ·Status: COMPLETED ·Phase: NA
-
Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)
NCT00348361 ·Status: COMPLETED ·Phase: PHASE1
-
Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.
NCT02230475 ·Status: COMPLETED
-
Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen
NCT01719133 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of a New Self-Assessed, Home-Based Symptom Score Test in Cat Allergic Patients
NCT02399579 ·Status: COMPLETED ·Phase: NA
-
Improved Basophil Activation Test (BAT) in the Diagnostics of Drug Allergy
NCT03164044 ·Status: UNKNOWN
-
A Novel Biologic Therapy for Perennial Allergic Rhinitis
NCT03360071 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders
NCT00557895 ·Status: TERMINATED
-
Clinical and Immunological Evaluation of Children With Allergies
NCT00102570 ·Status: COMPLETED
-
The Role of Filaggrin Mutations and Sensitization Pathways in Allergic Rhinitis and Peanut Allergy
NCT02745418 ·Status: ACTIVE_NOT_RECRUITING
-
Study In Adults And Adolescents With Seasonal Allergic Rhinitis.
NCT00225823 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy
NCT01720251 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of an Allergic Rhinitis Control Test in Children
NCT03075917 ·Status: RECRUITING ·Phase: NA
-
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3
-
A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies
NCT01054352 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy
NCT01451450 ·Status: WITHDRAWN ·Phase: PHASE2
-
Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis
NCT05098522 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effects of Single Dose Corticosteroids on Response to Allergens
NCT00828061 ·Status: COMPLETED ·Phase: PHASE1
-
Peanut and Tree Nut Desensitization
NCT03532360 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA